UK House of Commons: No Deal Brexit Exposes U.K. to Both Counterfeit Medication and Medication Shortages

In a report published by the House of Commons, experts in the field of prescription medication described a dire situation for medicine safety in the United Kingdom (UK) if a “no-deal” departure from the European Union (EU) happens. The report noted, “Witnesses told us that, without provisions with the EU to continue to exchange data, the UK would be shut out of critical EU data exchanges on pharmacovigilance, falsified medicines and clinical trials.”

[...]

Senator McSally Meets with Experts on the Counterfeit Drug Trade

The Arizona Republic has reported that Executive Director Shabbir Safdar, along with Maricopa County Sheriff Paul Penzone, Pinal County Sheriff Mark Lamb, U.S. Drug Enforcement Administration special agent in charge Doug Coleman, and Phoenix-area pharmacist Randle House and met with U.S. Senator Martha McSally in Arizona on August 8th to seek her assistance and support for efforts to protect the U.S. prescription drug supply from counterfeit medication

[...]

Canadians Concerned About US Prescription Drug Importation Proposals

John Adams of the Best Medicines Coalition, a Canadian group that represents 28 different patient organizations, has described the Trump administration’s plan to import medication from Canada as a “clear and present danger” to the Canadian prescription drug system, according to AP.

[...]

San Diego is in the Midst of a Deadly Counterfeit Pill Crisis, with 50 Confirmed Deaths Thus Far

U.S. Attorney Robert Brewer has issued a public safety warning concerning deadly counterfeit oxycodone pills in San Diego County. NBC San Diego reports, “The U.S. Attorney’s Office said border seizures, prosecutions and overdoses in San Diego County are on pace to reach all-time highs by the end of 2019. The Medical Examiner’s Office reports 50 confirmed fentanyl-related fatal overdoses so far this year, and says 28 more suspected cases are waiting to be confirmed.”

[...]

Partnership for Safe Medicines Statement on Reckless and Politically-Motivated Federal Drug Importation Proposal

Partnership for Safe Medicines Statement on Reckless and Politically-Motivated Drug Importation Proposal Washington, D.C. (July 31, 2019) – Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to today’s announcement by HHS Secretary Alex Azar and FDA Commissioner Ned Sharpless: “Less than a year and a half ago,…

[...]

ASOP Canada and 14 Other Canadian Patient Organizations Raise Alarm with Canadian Minister of Health on U.S. Drug Importation Proposals

The Canadian branch of the Alliance for Safe Online Pharmacies (ASOP), along with fourteen other Canadian patient advocacy organizations have written a letter to Canadian Health Minister, the Honorable Ginette Petitpas Taylor imploring her to prevent the United States from wiping out the Canadian prescription medication supply with their misguided importation proposals.

[...]